The genetic, mutational and phenotypic spectrum of deafness-causing genes shows great diversity and pleiotropy. The best examples are the group of genes, which when mutated can either cause non-syndromic hearing loss (NSHL) or the most common dual sensory impairment, Usher syndrome (USH). Variants in the CIB2 gene have been previously reported to cause hearing loss at the DFNB48 locus and deaf-blindness at the USH1J locus. In this study, we characterize the phenotypic spectrum in a multiethnic cohort with autosomal recessive non-syndromic hearing loss (ARNSHL) due to variants in the CIB2 gene. Of the 6 families we ascertained, 3 segregated novel loss-of-function (LOF) variants, 2 families segregated missense variants (1 novel) and 1 family segregated a previously reported pathogenic variant in trans with a frameshift variant.
variants into clinically actionable therapies and interventions is tied directly to the accuracy of the interpretation of genomic variants and ultimately the molecular diagnosis. Both missed-diagnosis and misdiagnosis yield non-ventured personalized therapeutic and intervention opportunities for patients. In genes that exhibit pleiotropy, such as the genes associated with Usher syndrome (USH), elucidating the phenotypic outcome based on the genetic data often alters treatment avenues and patient's quality of life.
Hereditary hearing loss (HHL) is the most common sensorineural defect, affecting roughly 1 in 500 newborns. 1 It is both genetically and phenotypically heterogeneous with over 150 genes causally associated with a wide range of phenotypic outcomes through a combinatorial effect of type (sensorineural or conductive), severity, frequencies affected, onset, progression and the presence or absence of other system defects (non-syndromic or syndromic). Adding an additional layer of complexity is the pleiotropy exhibited by several deafness-causing genes, best illustrated by USH, the most common dual sensory defect affecting hearing and vision. USH can be classified into 3 types depending on the auditory and retinal phenotypes.
The most severe, USH type 1 (USH1), is characterized by congenital severe-to-profound hearing loss, vestibular dysfunction and an onset of retinitis pigmentosa (RP) in the first decade of life. ple, while it is widely recognized that variants predicting null alleles cause USH, 3, 4 predicting the effect of missense variants is very difficult. It is often unclear which variants or variant combinations lead to an NSHL phenotype vs an USH phenotype.
CIB2 belongs to a highly conserved family of EF-hand domain containing and calcium-binding proteins. 5, 6 Functionally, their roles are either structural, affecting calcium binding, or regulatory, as part of intercellular calcium-dependent signaling cascades. [6] [7] [8] [9] [10] CIB2 comprises 3 EF-hand domains of which only the 2 most C-terminal have been shown functionally to bind calcium. 10, 11 In humans, there are 4 alternatively spliced transcripts of CIB2, which produce 4 proteins ranging in size from 138 amino acids (aa) to 192 aa. CIB2 is widely transcribed in many tissues including the inner ear and retina. 12 In the mouse inner ear, it is expressed in the hair cells, supporting cells and the vestibular system, where it interacts with 2 components of the Usher interactome, whirlin (WHRN) and myosin VIIa (MYO7A).
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In the mouse retina, CIB2 is broadly expressed in the retina pigment epithelium, inner and outer plexiform layers, the ganglion cell layer and the inner and outer segment of photoreceptors.
The pathogenic mechanism underlying CIB2-related deafness is unclear. Two mechanisms have been proposed: a decrease in CIB2 integrin-binding ability or a diminished capacity to properly buffer calcium. [12] [13] [14] Recent studies in several murine mutants suggest both mechanisms could be at play and might not be mutually exclusive 15, 16 . In humans, variants in CIB2 have been linked to hearing loss at the DFNB48 and USH1J loci. 12 Here, we present a multi-ethnic cohort of patients with autosomal recessive NSHL (ARNSHL) due to pathogenic variants in CIB2. We expand the mutational spectrum of CIB2 to include copy number variations (CNVs), splice-site variants
and indels, and demonstrate that regardless of variant-type or combination, all pathogenic variants in CIB2 in our cohort give rise to nonsyndromic deafness. These data call into question any involvement of CIB2 in the physiopathology of USH. individual from families L-3156 and 661 as previously described. [19] [20] [21] [22] Enriched libraries were sequenced on the Illumina HiSeq 2000 (Illumina Inc., San Diego, California) using 100-bp paired end reads.
| MATERIALS AND METHODS

| Patients and audiometric evaluations
| Bioinformatic analysis
Data analysis was performed using either a custom annotation pipeline 17, 19, 20 or the Illumina CASAVA v1.8 pipeline. 21, 22 In each instance, sequencing reads were mapped to the NCBI Build 37 reference genome using Burrows-Wheeler Aligner (BWA) 23 and variant calling was performed using Genomic Analysis Tool Kit. 24 Variants were annotated and filtered as described. 17, 19, 21 Briefly, variants were filtered based on depth > 10, quality score > 30 and minor allele frequency (MAF) <2% in Genome Aggregation Database (gnomAD), 1000
Genomes Project database, the Exome Aggregation Consortium (http://www.fruitfly.org/seq_tools/splice.html). In addition, samples captured using the OtoSCOPE platform were analyzed for CNVs using a sliding window method to asses read-depth ratios. 25 For families 661 and L-3156, visual inspection of the CIB2 gene using Integrated Genomics Viewer (IGV) (Broad Institute) was used to detect CNVs. All reported variants have been submitted to the University of Iowa Deafness Variation Database (http://deafnessvariationdatabase.org/) for curation and integration. 3 | RESULTS
| Molecular modeling
| Phenotypic characterization
The ascertained families originated from 3 ethnic backgrounds - 
| Linkage analysis
Homozygosity mapping and linkage analysis identified a single homozygous region with an Logarithm of the odds (LOD) score > 3 on chr15q22.2-q25.1. This region, which was shared by all affected siblings and generated a maximum LOD score of 3.6, spans 18.5 Mbp between rs951265 and rs2902957 and overlaps 2 known deafness loci: DFNB48 and DFNA30 ( Figure 1A ). The linked region harbors 246 genes.
Pedigrees showing haplotypes in the DFNB48 locus, audiometric data, funduscopy images and segregation for variants in CIB2. Nucleotide numbering: the A of the ATG translation initiation site is noted as +1 using transcript NM_006383 of CIB2. NSHL, non-syndromic hearing loss; USH1, Usher Syndrome Type 1; C, predicted Conserved; D, predicted Damaging or Deleterious; −, data not available; EF, EF-hand; PP2, PolyPhen-2; MT, MutationTaster. An "*" indicates a founder mutation identified in a total of 56 Pakistani families. Italics indicate previously described variants also identified in this study.
| Variant Identification and segregation
TGE and MPS using the OtoSCOPEv7 platform on probands from families L-1644, 51550, Trio-B and Trio-C yielded an average of 10 million reads per sample and a coverage of 99.5% at ≥10× and 98.5% at ≥30×. After filtering for quality and MAF, an average of 9 variants per sample was identified. CNVs were not detected in any of the samples.
Using a recessive model, we further filtered variants to include only variants that were either homozygous or compound heterozygous.
In family L-1644, only 1 homozygous variant was identified:
c.344A>G in CIB2 (NM_006383). This novel missense variant changes a conserved tyrosine residue to a cysteine, p.Tyr115Cys (NP_006374), and is predicted to be deleterious by PolyPhen-2, SIFT, MutationTaster, LRT and CADD (Table 2) . It is located in exon 4, thus affecting all alternatively spliced transcripts ( Figure 2A ) and the aa residue Tyr115, which is positioned in the second EF-hand domain of the protein ( Figure 2B ). Segregation analysis showed all affected individuals were homozygotes, whereas unaffected individuals were either heterozygous or wild type for this allele ( Figure 1B ). An ultra-rare homozygous splice-site variant in CIB2, c.198
+1G>A, was identified in the proband of 51550 ( Figure 1D ). Table 2) . It is located in the first EF-hand domain ( Figure 2B ). The second allele, c.300_309del is a rare frameshift variant that predicts a null allele and affects the coding sequence of all 4 transcripts (Table 2 ) (Figure 2A) .
A homozygous nonsense variant in CIB2, c.330T>A, p.Tyr110Ter was identified in the proband of family 661 and was found to segregate with the hearing loss in the family ( Figure 1C) . Variant results for this family have been reported previously without clinical correlation or details. 22 The variant is located in exon 4 produces a protein truncated at codon 110, which is located near the start of the second EF-hand domain ( Figure 2B ) and affects the coding sequence of all transcripts (Figure 2A ).
Ten variants passed filtering criteria for the proband of Trio-C. Of these, a homozygous previously reported pathogenic alteration in CIB2:
c.223G>A; p.Val75Met was identified ( Figure 1F ). This variant is located early in exon 4 and it affects the first EF-hand domain (Figure 2A,B) . were not predicted to be deleterious by any pathogenicity prediction tool (Table S2) . A variant in the PEAK1 gene (OMIM# 614248) was identified that is conserved and predicted to be deleterious (Table S2) . Direct sequencing showed this variant was homozygous in all individuals.
Assessing the coverage for each gene in the region using IGV revealed the absence of sequence reads mapping to exon 2 of CIB2 ( Figure 3A ).
PCR amplification using primers flanking exon 2 failed to generate a product for all affected individuals. Long-range PCR encompassing 8.8 kb around exon 2 resulted in 2 PCR products: a~8.8 kb and 5.7 kb product. Unaffected individuals have either both products or just the~8.8 kb product, whereas patients only have the~5.7 kb product ( Figure 3B ). The size of the deletion was determined to be 3113 bp with the breakpoints at chr15:78413407 and Chr15:78416520 ( Figure 3D ).
This CNV removes the coding exon 2 (c.52_86delGACTGCACCTTCTT-CAATAAGAAGGACATCCTCAA) from transcripts 1 and 4 ( Figure 2A) resulting in a frameshift and a truncated protein, p.Asp18Alafs*7
( Figure 2B ). Long-range PCR found the deletion to segregate with hearing loss in the extended family ( Figure 1A ). This CNV was absent in 96 ethnically matched controls and an additional 175 hearing impaired Iranian probands.
| DISCUSSION
We used targeted genomic enrichment and massively parallel sequencing to implicate CIB2 as the causal gene in 6 families (Table 2 ).
In humans, CIB2 has 4 alternatively spliced transcripts ( Figure 3A) .
While the expression pattern of each transcript has yet to be elucidated, the variants described here help to define which transcripts are essential for hearing. The p.Tyr110Ter variant affects all 4 transcripts of CIB2 (Figure 2A ) and if it escapes mRNA nonsense-mediated decay, would translate a truncated protein without its calcium-binding motifs ( Figure 2B ), thus producing a peptide lacking calcium-binding ability.
Previous functional analysis of the p.Arg66Trp variant revealed no effect on CIB2 localization in hair cells or its calcium-buffering ability. 14 However, the identification of this variant in CIB2 also opens the possibility for molecular intervention using short antisense oligonucleotides, which can be designed to target splicing variants. 27, 28 Whole exome sequencing (WES) for family L-3156 was carried out before the causative gene at the DFNB48 locus was discovered.
While investigating candidate variants identified in family L-3156, CIB2 was identified as the gene responsible for deafness at the DFNB48 locus. Reexamining the sequencing data uncovered no variants in the coding regions of CIB2; however, inspection of the coverage for CIB2 showed no reads mapping to exon 2. The deletion was confirmed using PCR primers spanning exon 2, which failed to gener- on data from other missense variants in CIB2, which do not have this type of impact. [12] [13] [14] [15] It is unclear whether CIB2 p.Cys115 would affect the interaction with TMC1 or TMC2. 15 The p.Val75Met variant has been previously described 17 ( Figure 1F ). The alteration replaces a small valine with the larger and bulkier sulfur-containing methionine ( Figure 2E ). This variant occurs in the EF-1 hand domain between 2 reported CIB2 variants, p.
Arg66Trp and p.Phe91Ser ( Figure 2B ). In vitro studies of these 2 variants revealed they do not affect CIB2's ability to localize to the tips of the stereocilia or its calcium-buffering property, but most likely perturb the CIB2-αIIβ integrin interaction. 14, 31, 32 Recent data suggest that the N-terminal region of CIB2 interacts with TMC1 and TMC2, and given the location the p.Val75Met change, it too may share the same deleterious functional characteristics -not affecting localization or calcium buffering, but rather weakening or abolishing CIB2's ability to interact with TMC1 and TMC2. 15 Of the 8 variants described in CIB2 to date, only 1 has been associated with USH1J, a p.Glu64Asp missense variant described in one Pakistani family. 12 The disease locus in the family was mapped to an interval spanning both DFNB48 and USH1H, and CIB2 was designated as the USH1J gene for 2 reasons. First, no variants were found in the family originally defining USH1H, and second, the critical linkage interval for USH1H did not overlap CIB2. . Missense variants in CIB2 also do not affect protein localization. [12] [13] [14] [15] There are also important phenotypic differences. Mouse models of USH caused by MYO7A, USH1C, CDH23, PDCH15 and USH1G (the genes responsible for USH1B, USH1C, USH1D, USH1F and USH1G, respectively, in humans) all share a common phenotype: congenital profound deafness and vestibular dysfunction manifested as a visible head-bobbing and circling phenotype. [35] [36] [37] [38] [39] [40] Notably, mice homozygous for the targeted deletion of CIB2 or targeted knock-in animals have profound deafness but no obvious severe vestibular phenotype. 15, 16 Ultrastructurally, while all USH1 mouse mutants exhibit hair cell disorganization and stereocilia defects, the CIB2 mutant does not share similar gross hair cell abnormalities. Thus, absence of CIB2 in the mouse inner ear does not compare phenotypically to absence of known USH1 proteins. 15, 16 In summary, we implicate CIB2 as the cause of congenital profound ARNSHL in 6 families representing 3 ethnicities. In so doing, we expand the genetic spectrum of CIB2 variants to include CNVs, splice-site variants and frameshift variants, and show that the phenotype associated with null alleles of CIB2 is ARNSHL and not USH.
Based on this observation and the available murine data, we believe CIB2 is causally related only to NHSL and not USH. This distinction is important as providing the correct molecular interpretation of genetic variants is critical to patient care, and in the case of USH vs NSHL, may define the intervention and prevention avenues available for patients. We acknowledge that more detailed studies are required to understand the role of CIB2 in the inner ear.
